- Filed
- Feb 4, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jan 28, 2025 | 128.28M sh |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $833.4M |
| Long Term Debt | Q1 2025 · Sep 30, 2024 | $833.1M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $49.6M |
| Cash And Equivalents | Q1 2025 · Sep 30, 2024 | $71.1M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $193.9M |
| Current Liabilities | Q1 2025 · Sep 30, 2024 | $203.7M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.03B |
| Total Liabilities | Q1 2025 · Sep 30, 2024 | $1.04B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $649.5M |
| Current Assets | Q1 2025 · Sep 30, 2024 | $592.7M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $885.2M |
| Total Assets | Q1 2025 · Sep 30, 2024 | $837M |
| Stockholders Equity | Q1 2025 · Sep 30, 2024 | −$205.9M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$286.9M |
| Shares Diluted | Q1 2025 · Dec 31, 2023 | 133M sh |
| Stock Repurchased | Q1 2025 · Dec 31, 2023 | $9.4M |
| Capex | Q1 2025 · Dec 31, 2023 | $200K |
| Operating Cash Flow | Q1 2025 · Dec 31, 2023 | $74.2M |
| Eps Diluted | Q1 2025 · Dec 31, 2023 | $0.33 |
| Eps Basic | Q1 2025 · Dec 31, 2023 | $0.33 |
| Sga Expense | Q1 2025 · Dec 31, 2023 | $52.8M |
| Net Income | Q1 2025 · Dec 31, 2023 | $43.9M |
| Operating Income | Q1 2025 · Dec 31, 2023 | $73M |
| Gross Profit | Q1 2025 · Dec 31, 2023 | $148M |
| Cost Of Revenue | Q1 2025 · Dec 31, 2023 | $282.4M |